Ileal immune tonus is a prognosis marker of proximal colon cancer in mice and patients
Open Access
- 1 December 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cell Death & Differentiation
- Vol. 28 (5), 1532-1547
- https://doi.org/10.1038/s41418-020-00684-w
Abstract
Ileal epithelial cell apoptosis and the local microbiota modulate the effects of oxaliplatin against proximal colon cancer by modulating tumor immunosurveillance. Here, we identified an ileal immune profile associated with the prognosis of colon cancer and responses to chemotherapy. The whole immune ileal transcriptome was upregulated in poor-prognosis patients with proximal colon cancer, while the colonic immunity of healthy and neoplastic areas was downregulated (except for the Th17 fingerprint) in such patients. Similar observations were made across experimental models of implanted and spontaneous murine colon cancer, showing a relationship between carcinogenesis and ileal inflammation. Conversely, oxaliplatin-based chemotherapy could restore a favorable, attenuated ileal immune fingerprint in responders. These results suggest that chemotherapy inversely shapes the immune profile of the ileum–tumor axis, influencing clinical outcome.This publication has 39 references indexed in Scilit:
- Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor MicroenvironmentScience, 2013
- Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human CancerImmunity, 2013
- Diversified pattern of the human colorectal cancer microbiomeGut Pathogens, 2013
- Reciprocal interactions of the intestinal microbiota and immune systemNature, 2012
- IL-17+ Regulatory T Cells in the Microenvironments of Chronic Inflammation and CancerThe Journal of Immunology, 2011
- Colon carcinoma – Classification into right and left sided cancer or according to colonic subsite? – Analysis of 29 568 patientsEuropean Journal of Surgical Oncology, 2011
- Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal nicheNature, 2009
- Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cellsProceedings of the National Academy of Sciences of the United States of America, 2008
- The Adaptive Immunologic Microenvironment in Colorectal Cancer: A Novel PerspectiveCancer Research, 2007
- Generation of gut‐homing T cells and their localization to the small intestinal mucosaImmunological Reviews, 2007